Clinical Trials Browser

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphoma, Large B-Cell, Diffuse

Pancreatic Neoplasms

Lymphoma, T-Cell

Lymphoma, T-Cell, Peripheral

Leukemia, Myeloid, Acute

Leukemia, Monocytic, Acute

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Infections, Epstein-Barr Virus Infections

HR+/HER2- Advanced Breast Cancer

Lymphoma, T-Cell, Peripheral

Triple Negative Breast Neoplasms

Advanced Colorectal Cancer in the Third-line Treatment and Beyond

Colorectal Neoplasms

Leukemia, Myeloid, Acute

Lymphoma, T-Cell, Peripheral

Lymphoma, T-Cell, Peripheral

Colorectal Neoplasms

Urinary Bladder Neoplasms

Colorectal Cancer Metastatic

Colorectal Cancer Metastatic

Sarcoma, Osteosarcoma

Lymphoma, T-Cell, Peripheral

Lymphoma, Large B-Cell, Diffuse

Lymphoma, T-Cell

Lymphoma, Non-Hodgkin

Breast Neoplasms

Osteosarcoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Leukemia, Myeloid, Acute, Neoplasm, Residual

Breast Neoplasms

Lymphoma, T-Cell, Cutaneous

Lymphoma, Large B-Cell, Diffuse

HR+/HER2- Advanced Breast Cancer

Lymphoma, T-Cell, Peripheral

Colorectal Neoplasms

Recurrence, Leukemia, Myeloid, Acute

Esophageal Squamous Cell Carcinoma

Breast Neoplasms

Breast Neoplasms

HR+/HER2- Breast Cancer

Lymphoma, Large B-Cell, Diffuse

Leukemia, Myeloid, Acute

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

CM-AML-001

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Golidocitinib With Azacitidine and Chidamide in Patients With Peripheral T-cell Lymphoma.

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

VAC Regimen for AML Patients Who Failed to Response to VA Regimen

Chidamide Plus Golidocitinib in Relapsed/Refractory Peripheral T-Cell Lymphoma

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

Chidamide + Celecoxib in Advanced Metastatic Colorectal Cancer (CCmCC)

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL).

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma

Chidamide Bridging for CAR-T Therapy

CINDERELLA

Chidamide Combined With Toripalimab in Sarcoma

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients

A Study of Chidamide With AZA in MRD Positive AML After Transplant

NeoTEE

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer.

Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

TRUMP